George Cardoza joined AccuraGen following a 12+ year tenure at NeoGenomics Laboratories where he served as Chief Financial Officer (CFO) from 20092018; President, Pharma Services Division from 20182021; and as President and Chief Operating Officer (COO), Lab Operations from 20212022. Earlier in his career Cardoza served as CFO at Protocol Integrated Direct Marketing and several positions at Quest Diagnostics including Controller, Central Region. George earned his Bachelors Degree in Finance and Accounting from Syracuse University and his M.B.A. in Management from Michigan State University Eli Broad College of Business.
Clinical Dx Showcase:
AccuraGen aims to revolutionize cancer management through technology innovation in molecular testing. AccuraGen focuses on the analysis of highly fragmented circulating nucleic acid in blood and has developed proprietary technologies enabling superior performance in the analysis of genomic, epigenetic, and RNA changes.
Company Introduction and Leading Liquid Biopsy Platform
A unique liquid biopsy platform that offers best-in-class early cancer detection solution
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.